< Back to the Blog

About the author

Amy Divaraniya
Dr. Aparna (Amy) Divaraniya is the Founder and CEO of Oova. She has over 10 years experience working in data science and a PhD in Biomedical Sciences. In 2017, Amy pivoted to women's healthcare after facing her own fertility struggles. Amy started Oova to give women control over their fertility by making high-quality hormone testing more accessible.

Sources

  1. American College of Obstetricians and Gynecologists (ACOG). Management of Menopause-Related Vasomotor, Sleep, and Mood Symptoms. Clinical Practice Guideline No. 13. Obstet Gynecol. 2026;148(5)–e369. doi:10.1097/AOG.0000000000006428.
  2. Qaseem A, Mackey K, Yost J, et al. Pharmacologic Treatments for Females With Menopausal Vasomotor Symptoms: A Clinical Guideline From the American College of Physicians. Ann Intern Med. Published online October 6, 2026. doi:10.7326/ANNALS-26-01205.
  3. The Menopause Society. The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. Menopause. 2022;29(7):767–794. PubMed.
  4. National Institute for Health and Care Excellence (NICE). Menopause: Identification and Management. NICE Guideline NG23. Published November 12, 2015; updated April 15, 2026. NICE NG23.
  5. Faculty of Sexual & Reproductive Healthcare (FSRH). Contraception for Women Aged Over 40 Years. Published 2017; amended July 2023, with subsequent updates. FSRH Clinical Guideline.

About the Oova Blog:
‍Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.